ARTICLE | Clinical News
ALN-PCSsc: Phase II started
February 15, 2016 8:00 AM UTC
The Medicines Co. began the double-blind, placebo-controlled, international Phase II ORION-1 trial to evaluate single or multiple, quarterly or biannual subcutaneous ALN-PCSsc in about 480 patients wi...